Amphista Therapeutics Enters Strategic Collaboration with Merck for Discovery and Development of Targeted Protein Degradation Therapeutics Read more
Sapience Therapeutics Receives FDA Orphan Drug Designation for ST101 for the Treatment of Advanced Melanoma Read more
Agastiya Biotech receives FDA Orphan Drug Designation for AB001 for Pancreatic cancer and Acute Myeloid Leukemia (AML) Read more
STORM Therapeutics Awarded Innovate UK Grant to Discover and Develop a Novel Coronavirus Therapy Targeting an RNA-Modifying Enzyme Read more
Genesis Therapeutics Announces Strategic Collaboration with Lilly to Discover Novel Therapies Using the Genesis Molecular AI Platform Read more
Nicoya Completes Acquisition of LSK Technologies, Expanding Digital Platform into Molecular Testing Read more
Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar Read more
Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) Read more